Everand Logo

Welcome to Everand!

  • STAT

    As congressional hearing looms, Sanofi cuts insulin prices for some patients

    Sanofi's program will lower the cost of the diabetes treatment to $99 a month for uninsured patients and others who pay cash in the U.S.
    by Ed Silverman Apr 10, 2019 3 minutes
    Source: Paul Griggs/Wellcome Images

    Just hours before one of its executives is set to testify at a Congressional hearing to review insulin pricing, Sanofi (SNY) on Wednesday offered a program that will lower the cost of the diabetes treatment to $99 a month for uninsured patients and others who pay cash in the U.S.

    Under the plan, the drug maker maintained patients can buy up to 10 boxes of insulin pens or vials with a valid prescription, beginning in June, and expands a program

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About CVS And Humira Biosimilars, Schumer’s Broken Insulin Promise, And More
    New prescriptions for biosimilar versions of Humira, one of the best-selling drugs in the U.S., surged to 36% from just 5% during the first week of April.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About AstraZeneca CEO Pay, Alternatives To WuXi And More
    And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans.…
    STAT1 min readAmerican Government
    Opinion: As A Rule, Rape Exceptions For Abortion Don’t Work
    Abortion opponents often say they want to support survivors of rape. But abortion bans do the opposite, and no fake "rape exception" is going to change that.

    Related Books & Audiobooks